Friday, June 7, 2013

• ImmunoCellular Therapeutics Announces Recommendation of Data Monitoring Committee to Continue ICT-107 Phase II Trial Following Interim AnalysisBusiness Wire( (Fri, Jun 7)

Monday, June 3, 2013

• NeoStem's Subsidiary, PCT, Enters Into a Manufacturing Agreement With ImmunoCellular Therapeutics, Ltd. for Dendritic Cell Vaccines Targeting Brain and Other CancersGlobeNewswire( (Mon, Jun 3)

Wednesday, May 22, 2013

• ImmunoCellular Therapeutics to Present at Marcum MicroCap Conference on May 30thBusiness Wire( (Wed, May 22)

Thursday, May 16, 2013

• ImmunoCellular Therapeutics Announces Issuance of Key Patent Covering ICT-107 Cancer Vaccine TargetBusiness Wire( (Thu, May 16)

Thursday, May 9, 2013

• ImmunoCellular Therapeutics Announces First Quarter 2013 Financial ResultsBusiness Wire( (Thu, May 9)

Wednesday, May 1, 2013

• ImmunoCellular Therapeutics to Report Financial Results for the First Quarter 2013 May 9, 2013Business Wire( (Wed, May 1)

Thursday, March 28, 2013

• ImmunoCellular Therapeutics to Present at Future Leaders Conference on April 5thBusiness Wire( (Thu, Mar 28)

Monday, March 11, 2013

• ImmunoCellular Therapeutics to Present at ROTH Conference on March 18thBusiness Wire( (Mon, Mar 11)

Tuesday, March 5, 2013

• ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2012 Financial ResultsBusiness Wire( (Tue, Mar 5)

Monday, March 4, 2013

• ImmunoCellular Therapeutics Announces Issuance of Key Patent for ICT-121 Cancer VaccineBusiness Wire( (Mon, Mar 4)

Tuesday, February 26, 2013

• ImmunoCellular Therapeutics to Report Financial Results for the Fourth Quarter and Full Year 2012 on March 5, 2013Business Wire( (Tue, Feb 26)

Wednesday, February 20, 2013

• Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry's SuccessMarketwired( (Wed, Feb 20)